Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel.

IF 7.1 1区医学 Q1 HEMATOLOGY

Blood advances Pub Date : 2025-09-30 DOI:10.1182/bloodadvances.2025017012

Lauren Elizabeth Appell, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly L Pacenta, Samuel John, Vanessa A Fabrizio, Christine L Phillips, Jenna Rossoff, Julie-An M Talano, Amy Moskop, Rachel Phelan, Susanne H C Baumeister, Michael R Verneris, Erin M Hall, Gary Douglas Myers, Nicole A Karras, Stacy Cooper, Muna Qayed, Sunil Sudhir Raikar, Lena E Winestone, Michelle L Hermiston, Prakash Satwani, Christa Krupski, Amy Keating, Danielle Novetsky Friedman, Kevin J Curran, Alex Hoover, Margaret L MacMillan, Christen L Ebens, Archana Ramgopal, April L Rahrig, Crystal L Mackall, Theodore W Laetsch, Liora M Schultz

引用次数: 0

查看原文本刊更多论文

放宽接受tisagenlecucel治疗的低负荷B-ALL儿童/年轻人的医院邻近要求。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Blood advances Medicine-Hematology

CiteScore

12.70

自引率

2.70%

发文量

840

期刊介绍： Blood Advances, a semimonthly medical journal published by the American Society of Hematology, marks the first addition to the Blood family in 70 years. This peer-reviewed, online-only, open-access journal was launched under the leadership of founding editor-in-chief Robert Negrin, MD, from Stanford University Medical Center in Stanford, CA, with its inaugural issue released on November 29, 2016. Blood Advances serves as an international platform for original articles detailing basic laboratory, translational, and clinical investigations in hematology. The journal comprehensively covers all aspects of hematology, including disorders of leukocytes (both benign and malignant), erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. Each article undergoes a rigorous peer-review process, with selection based on the originality of the findings, the high quality of the work presented, and the clarity of the presentation.